AGL Past Earnings Q&A
What was the best and worst AGL past earnings results?
For Agilon Health, I'm wondering what the company's very best and worst earnings results have been, on an earnings per share basis?
The highest AGL past earnings result in our data set was 0.040/share posted in Q1 2023, while the lowest was in Q2 2021 when AGL posted -0.790/share.
The biggest top line earnings performance — aka revenue — quarter was in Q3 2023 when AGL reported 1.22B in revenue, while the quarter with the lowest revenue in our data set was Q1 2021 at 0.41B of revenue.
There are 11 AGL past earnings results in our data set.
On this page we presented the AGL past earnings date information for Agilon Health. Reviewing that
AGL Past Earnings
for the company, we see that the highest past earnings result in our data set was in Q1 2023, when AGL posted gaap of 0.040/share. Meanwhile the lowest AGL past earnings result was in Q2 2021, when AGL posted gaap of -0.790/share. Turning to top line revenue performance, the biggest revenue quarter in our data set was seen in Q3 2023 when AGL reported 1.22B in revenue, while the smallest revenue quarter was Q1 2021 when AGL reported 0.41B in revenue.
Any self directed investor doing their due diligence on AGL or any other given stock can benefit from
researching all of the Agilon Health past earnings — and here, we present each quarter's result all together
on one page for easy comparison. Studying this information can help when projecting future earnings, as well
as determining whether the past earnings trajectory justifies the current stock value.
That's why we bring you PastEarnings
.com to make it easy for investors to investigate
Agilon Health past earnings, or the past earnings information for any stock in our coverage universe.
And in your continued research we hope you will be sure to check out the further links included for earnings
surprises history (beat/miss data) as well as next earnings dates for AGL. Thanks for visiting, and the next
time you need to research AGL past earnings
or those of another stock, we hope you'll think of our site, as your
go-to past earnings research resource of choice.